NBD AI Bulletin -- Guangzhou Kingmed Diagnostics Group Co., Ltd (SH 603882, close price: 92.48 yuan) on September 16 announced that the Company's shareholder Guokai Boyu has completed the stock reduction plan, offloading about 2.55 million shares, accounting for 0.55% of the Company's total equity.
The 2020 annual report shows that Guangzhou Kingmed Diagnostics Group Co Ltd's main business is third-party medical diagnosis, accounting for 95.46% of revenue.
The general manager and chairman of Guangzhou Kingmed Diagnostics Group Co Ltd is Liang Yaoming, male, 57 years old, without overseas permanent residency, with a master's degree in busniess administration, and a bachelor's degree in clinical medicine.
(By Gao Han)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.